Tweet
From an old post.
__________________________________________________ ____
2015
__________________________________________________
“USADA is a drug-testing agency. USADA should not be granting waivers and exemptions.”
— Bob Bennett NSAC director
In a letter to Montoya dated May 23, 2012, Spitz wrote: "...(Montoya) asserted to the Nevada State Athletic Commission that (he has) received information that Golden Boy attempted to obtain an agreement from the Voluntary Anti-Doping Agency (VADA) not to disclose a potential B sample test until after the tested boxer had participated in the scheduled fight. (Montoya) further asserted that Golden Boy had entered into an agreement with the U.S. Anti-Doping Agency (USADA) which contained such a provision. You have also claimed that Golden Boy entered into a contract with USADA for testing in connection with Floyd Mayweather fights which provided inadvertant use exemption that would permit a positive test to be excused if the result were inadvertant use. And that Mayweather had tested positive on three occasions which were excused under the inadvertant use provision."
2015
It was announced publicly that the bout contract Mayweather and Pacquiao signed in February 2015 to fight each other provided that drug testing would be conducted by USADA. But the actual contract with USADA remained to be negotiated. In early March, USADA presented the Pacquiao camp with a contract that allowed the testing agency to grant a retroactive therapeutic use exemption (TUE) to either fighter in the event that the fighter tested positive for a prohibited drug. That retroactive exemption could have been granted without notifying the Nevada State Athletic Commission or the opposing fighter’s camp.
Team Pacquiao thought that was outrageous and an opportunity for Mayweather to game the system. Pacquiao refused to sign the contract.
Thereafter, Mayweather and USADA agreed to mutual notification and the limitation of retroactive therapeutic use exemptions to narrowly delineated circumstances. With regard to notice, a copy of the final USADA-Mayweather-Pacquiao contract provides: “Mayweather and Pacquiao agree that USADA shall notify both athletes within 24 hours of any of the following occurrences: (1) the approval by USADA of a TUE application submitted by either athlete; and/or (2) the existence of and/or any modification to an existing approved TUE. Notification pursuant to this paragraph shall consist of and be limited to: (a) the date of the application; (b) the prohibited substance(s) or method(s) for which the TUE is sought; and (c) the manner of use for the prohibited substance(s) or method(s) for which the TUE is sought.”
Team Pacquiao thought that was outrageous and an opportunity for Mayweather to game the system. Pacquiao refused to sign the contract.
Thereafter, Mayweather and USADA agreed to mutual notification and the limitation of retroactive therapeutic use exemptions to narrowly delineated circumstances. With regard to notice, a copy of the final USADA-Mayweather-Pacquiao contract provides: “Mayweather and Pacquiao agree that USADA shall notify both athletes within 24 hours of any of the following occurrences: (1) the approval by USADA of a TUE application submitted by either athlete; and/or (2) the existence of and/or any modification to an existing approved TUE. Notification pursuant to this paragraph shall consist of and be limited to: (a) the date of the application; (b) the prohibited substance(s) or method(s) for which the TUE is sought; and (c) the manner of use for the prohibited substance(s) or method(s) for which the TUE is sought.”
“USADA is a drug-testing agency. USADA should not be granting waivers and exemptions.”
— Bob Bennett NSAC director
Comment